Peter Goodfellow

Chairman at

Gammadelta Therapeutics Ltd.

74 year

79 connections

Health Technology

Consumer Services

Commercial Services

Profile

Peter Goodfellow is currently the Chairman at Gammadelta Therapeutics Ltd., Adaptate Biotherapeutics Ltd., and Senior Advisor at Abingworth LLP.
Previously, he held positions as Director at deCODE genetics, Inc., Director at The Institute of Cancer Research: Royal Cancer Hospital, Director-Supervisory Board at Prosensa Holding NV, Director at Muscular Dystrophy Campaign Ltd., and Director at Virion Biotherapeutics Ltd. He also served as Senior Vice President-Discovery Research at GSK Plc and as a Professor at the University of Cambridge.
Dr. Goodfellow obtained a doctorate degree from the University of Oxford and completed undergraduate and doctorate degrees at the University of Bristol.

Peter Goodfellow active positions

Companies	Position	Start
Gammadelta Therapeutics Ltd. Gammadelta Therapeutics Ltd. BiotechnologyHealth Technology Operates biotechnology company that engages in discovery and development of allogeneic gamma delta T cell therapies for cancer	Chairman	-
Adaptate Biotherapeutics Ltd. Adaptate Biotherapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on biotechnology	Chairman	-
Abingworth LLP Abingworth LLP Investment ManagersFinance Abingworth invests in both private and public companies located across Europe and the United States. The firm targets companies operating in the fields of life sciences and healthcare sectors. It provide financing for seed, early, later and clinical co-development stage capital requirements with an investment size of USD 15 - 30 million.	Consultant / Advisor	-

All active positions of Peter Goodfellow

Former positions of Peter Goodfellow

Companies	Position	End
GENSIGHT BIOLOGICS S.A.	Director/Board Member	2023-06-20
deCODE genetics, Inc. deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology Is a bio-pharmaceutical company	Director/Board Member	2010-07-12
GSK PLC	Chief Tech/Sci/R&D Officer	-
University of Cambridge University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-
Virion Biotherapeutics Ltd. Virion Biotherapeutics Ltd. BiotechnologyHealth Technology Engages in research in biotechnology for developing therapies for respiratory viral infections	Director/Board Member	-

See the detail of Peter Goodfellow's experience

Training of Peter Goodfellow

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Peter Goodfellow's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	13
deCODE genetics, Inc. deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology Is a bio-pharmaceutical company	Health Technology
The Institute of Cancer Research: Royal Cancer Hospital The Institute of Cancer Research: Royal Cancer Hospital Miscellaneous Commercial ServicesCommercial Services Operates as a cancer research institution	Commercial Services
GSK Plc GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products	Health Technology
Abingworth LLP Abingworth LLP Investment ManagersFinance Abingworth invests in both private and public companies located across Europe and the United States. The firm targets companies operating in the fields of life sciences and healthcare sectors. It provide financing for seed, early, later and clinical co-development stage capital requirements with an investment size of USD 15 - 30 million.	Finance
University of Oxford University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Cambridge University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Bristol University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Prosensa Holding NV Prosensa Holding NV BiotechnologyHealth Technology Engages in the development of ribonucleic acid-modulating or RNA-modulating, therapeutics for the treatment of genetic disorders	Health Technology
Muscular Dystrophy Campaign Ltd.
Gensight Biologics SA Gensight Biologics SA Pharmaceuticals: MajorHealth Technology Manufactures and markets novel therapies for severe retinal neurodegenerative diseases	Health Technology
Gammadelta Therapeutics Ltd. Gammadelta Therapeutics Ltd. BiotechnologyHealth Technology Operates biotechnology company that engages in discovery and development of allogeneic gamma delta T cell therapies for cancer	Health Technology
Virion Biotherapeutics Ltd. Virion Biotherapeutics Ltd. BiotechnologyHealth Technology Engages in research in biotechnology for developing therapies for respiratory viral infections	Health Technology
Adaptate Biotherapeutics Ltd. Adaptate Biotherapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on biotechnology	Commercial Services